CHRONIC GRANULOMATOUS DISEASE (CGD)
Last Updated : 4/2/2007
Dr. Ira Shah
More..
What is

chronic granulomatous disease (CGD)

?

Chronic granulomatous disease also called as CGD is a primary immunodeficiency where the body's cells (phagocytes) are unable to kill the germs.

Why the phagocytes are unable to kill the germs?
Patients with CGD have defective phagocytes. These phagocytes are unable to form hydrogen peroxide and other oxidants that are needed to kill the germs. They are thus susceptible to infections by certain germs that need hydrogen peroxide to kill it.

What are the

symptoms of chronic granulomatous disease

?

Symptoms of CGD include recurrent infections due to specific bacteria and fungi especially skin or bone infection with a bacteria called serratia marcasens; lung infections by a fungus called aspergillus and pneumonias by other organisms such as Burkholderia cepacia, klebsiella pneumonias, nocardia. Abscesses due to staphylococci are also quite common. Patients with CGD are healthy at birth and then develop infections in the first few months or years of life. Skin, lungs, lymph nodes, liver, bones and brain are usual sites of infection.

How is the

diagnosis of chronic granulomatous disease

made?

Chronic granulomatous disease commonly occur in boys but about 15% of CGD patients are girls, CGD should be suspected in any patient who has pneumonia due to aspergillus, nocardia or Burkholderia cepacia or liver abscess due to staphylococcus or bone infection due to serratia marcascens. Diagnosis of CGD is established by doing Nibroblue Tetrazolium (NBT) test. NBT test measures the production of hydrogen peroxide by phagocytes. In patients with CGD, NBT test shows no hydrogen peroxide production by the phagocytes. NBT test is a manual test in which phagocytes producing hydrogen peroxide turn blue when in contact with the chemical called dihydrorhodamine. These cells are then counted manually using a microscope and thus NBT test is subject to human error.

What is the

treatment of chronic granulomatous disease

?

Treatment of CGD consists of prompt and aggressive treatment of infections. In patients with frequent infections, daily small dose of antibiotics (commonly used antibiotic is cotrimoxazole) can help to prevent infection. Patients with CGD are also treated with gamma-interferon to boost their immunity and decrease number of infections. Gamma-interferon is a protein produced by the immune system that stimulates the phagocytes to kill the bacteria more efficiently. It is given thrice weekly by subcutaneous injection. It is most effective in children under 10 years of age. However side effects in form of fever, muscle aches and headaches may be seen in few patients. To decrease frequency of fungal infections, itraconazole (an antifungal) can be given daily. The curative therapy for CGD is bone marrow transplant.

What are the

precautions required in a patient with chronic granulomatous disease

?

Patients with CGD need to take few precautions. They should avoid swimming in fresh water lakes or seas to prevent exposure to the germs. They should avoid handling of garden mulch (shredded moldy tree bark) as it increases risk of aspergillosis. Patient should also avoid gardening, cleaning dusty or moldy areas.

How is chronic granulomatous disease inherited?
CGD is a genetic disease and can be passed on in families. If passed on through the X-chromosome, it affects the boys and this form of transmission is seen in 75% of cases. If passed from other chromosomes, both boys and girls can be affected. There are very few specialized labs that do genetic testing for CGD.



Contributor Information and Disclosures

Dr. Ira Shah
Consultant Pediatrician, Nanavati Hospital and B.J.Wadia Hospital for Children, Mumbai


First Created : 2/5/2001

References

Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.